Home » Authors » Jim Stommen

Articles by Jim Stommen

Further advances for new hips, knees to ‘fit’ what patients want

Sep. 25, 2007

Conference offers good look at what ‘makes’ products high-tech

Sep. 24, 2007

CardioVations rolls out new Port Access line of instruments

Aug. 1, 2007

CardioVations rolling out new Port Access instrument line

July 16, 2007

Frost & Sullivan Medical Technologies 2006: Physician says assessment panel is a valuable approach

March 22, 2006

Frost & Sullivan Medical Technologies 2006: Sessions take a global look at doing med-tech business

March 21, 2006

Frost & Sullivan Medical Technologies 2006: Distribution accords seen as growth option for start-ups

March 20, 2006

Frost & Sullivan Medical Technologies 2006: Passion, execution cited as key elements for start-ups

March 17, 2006

Reimbursement issues termed key factor for device sector

March 16, 2006

Frost & Sullivan Medical Technologies 2006: Reimbursement issues termed key factor for device sector

March 16, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 18, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 18, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...